Evidence map›Paper›PMID 38239272›Full record

ArticleCase reports in oncological medicine2024

Metastatic Ovarian Serous Adenocarcinoma Clinically Presenting as Inflammatory Breast Cancer.

Lingling Xian, Rachel Hunter, Emily Smith, Rasha Mohammed, Carlina Madelaire, Guillermo A Herrera, Rodney E Shackelford

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncological medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lingling XianDepartment of Pathology, University of South Alabama, 2451 University Hospital Drive, Mobile, AL 36617, USA.
Rachel HunterDepartment of Surgery, University of South Alabama, 1601 Center Street, Suite 2k, Mobile, AL 36604, USA.
Emily SmithDepartment of Surgery, University of South Alabama, 1601 Center Street, Suite 2k, Mobile, AL 36604, USA.
Rasha MohammedDepartment of Pathology, University of South Alabama, 2451 University Hospital Drive, Mobile, AL 36617, USA.
Carlina MadelaireDepartment of Pathology, University of South Alabama, 2451 University Hospital Drive, Mobile, AL 36617, USA.
Guillermo A HerreraDepartment of Pathology, University of South Alabama, 2451 University Hospital Drive, Mobile, AL 36617, USA.
Rodney E ShackelfordDepartment of Pathology, University of South Alabama, 2451 University Hospital Drive, Mobile, AL 36617, USA.ORCID https://orcid.org/0000-0002-1129-5161
University of South Alabama · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastatic disease to the breast is a rare event, accounting for 0.5-2% of all breast cancers. Outside of metastases from the contralateral breast, malignant ovarian epithelial tumors are the most common origin of these metastases. Here, we present a very rare case of a high-grade ovarian serous adenocarcinoma presenting clinically as inflammatory breast cancer in a 70-year-old woman.

Identifiers

PMID38239272
PMCPMC10794072
OpenAlexW4390705221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.